Section Arrow
Quote
DRUG.NASDAQ
- Bright Minds Biosciences
Quotes are at least 15-min delayed:2026/04/14 19:25 EDT
After Hours
Last
 90.3
+1.16 (+1.30%)
Bid
86
Ask
100
High 90.88 
Low 89.07 
Volume 161 
Regular Hours (Closed)
Last
 89.14
+3.96 (+4.65%)
Day High 
90.36 
Prev. Close
85.18 
1-M High
87 
Volume 
99.09K 
Bid
86
Ask
100
Day Low
85.21 
Open
85.21 
1-M Low
66.2 
Market Cap 
833.67M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 77.39 
20-SMA 74.76 
50-SMA 77.73 
52-W High 123.75 
52-W Low 23.175 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.76/-9.12
Enterprise Value
833.71M
Balance Sheet
Book Value Per Share
6.59
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
HOTHHoth Therapeutics0.6459+0.134+26.18%-- 
After Hours 0.6499 +0.004 +0.62%
ALLOAllogene Therapeutics2.28-0.78-25.49%-- 
After Hours 2.19 -0.09 -3.95%
VRAXVirax Biolabs Group Limited0.148-0.0184-11.06%-- 
After Hours 0.1384 -0.0096 -6.49%
CMNDClearmind Medicine Inc.0.91-0.52-36.36%-- 
After Hours 0.8558 -0.0542 -5.96%
REPLReplimune Group1.95+0.25+14.71%-- 
After Hours 1.9001 -0.0499 -2.56%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.